How to Start a Peptide Telehealth Business

Founders ask how to start a peptide telehealth business more than almost any other question we hear. The honest answer starts with a distinction most of the internet blurs: selling peptide vials online and running a peptide telehealth brand are two completely different businesses, and only one of them is built to last. Here is the founder-level checklist, stated carefully, because careful is the whole game in this category.

Research-use-only sellers vs. prescription telehealth

Research-use-only (RUO) sellers ship vials labeled "for research purposes only" or "not for human consumption" straight to consumers. There is no provider, no prescription, no licensed pharmacy, and no patient record. The label does not make the model safe: when the marketing, the dosing chatter, or the customer base point to human use, regulators treat it accordingly, and payment processors and ad platforms tend to shut these businesses down without warning. It is not telehealth, and it is not clinical care.

Prescription telehealth looks like everything else in legitimate medicine. A patient completes an intake, a licensed provider evaluates that individual patient, and, where clinically appropriate AND legally permitted, the provider prescribes a preparation compounded by a licensed pharmacy, which ships it to the patient. Provider decision, patient-specific prescription, licensed pharmacy. No shortcuts. If you are running an RUO operation today and want out, we wrote a separate guide on moving a research peptide business to compliant telehealth.

The catalog is set by the FDA, not by you

This is the part founders most need to hear. Which peptides a pharmacy can lawfully compound is governed by federal compounding law, the FDA's ongoing evaluation of bulk drug substances, and state pharmacy rules. Those determinations change. Ingredients get reviewed, reclassified, and restricted, and the timelines belong to the FDA, not to any brand or launch partner. We cover the regulatory backdrop in more depth in can you sell peptides online legally.

The practical consequence: a compliant peptide brand's catalog is limited to what its licensed pharmacy partners can lawfully compound at the time, and that catalog can grow or shrink. That is why this guide does not name specific peptides to sell. Any list would age badly, and some of it could be wrong the week it was published. Before anything appears on your website or in an ad, confirm current status with your pharmacy partner and healthcare counsel, and re-confirm on a regular schedule after launch. Anyone who promises you a specific peptide will be available indefinitely is selling certainty nobody owns.

Checklist: the clinical layer

You do not need to be a clinician. Most founder-led telehealth brands run on a management services (MSO) model: the founder owns the brand and the business operations, and licensed providers make every prescribing decision. Corporate practice of medicine rules vary by state, so the structure should be reviewed by healthcare counsel.

A provider network licensed in the states you serve, with protocols for each category in your catalog. The provider is the clinical gate, and a real gate means some patients are told no. That is a feature of a durable business, not a leak in the funnel.

Licensed pharmacy partners. 503A pharmacies compound against patient-specific prescriptions; 503B outsourcing facilities operate under a different federal framework. Your partners determine what is lawfully available, how it ships, and whether cold-chain handling is required.

An intake built with your providers, not copied from a competitor. Screening questions, medical history, current medications, and contraindications all route to the provider before any prescription is written. Where a protocol calls for lab work, at-home labs should be wired into that same flow.

Ongoing care, not a one-time sale. Plan follow-up check-ins, a clear way for patients to message their care team, and a route for clinical questions to reach a provider rather than a sales inbox. Anything urgent should be directed to emergency care. This is the difference between a pharmacy storefront and a telehealth practice.

Checklist: the compliance layer

LegitScript certification. Major ad platforms and many payment processors require it for healthcare and pharmacy-adjacent brands. GrowPro files through its LegitScript Enterprise account, and the certification is issued to the founder's company, so you own it.

Marketing language is a compliance surface. No efficacy promises, no "healing" claims, no disease-treatment claims, no before-and-after theater, and never imply a specific peptide is available unless it is lawfully compoundable at that moment. Education-first creative is what ad platforms and LegitScript expect in this category, and it tends to build more trust anyway.

Privacy and data. HIPAA obligations apply to how patient information is collected, stored, and shared, including business associate agreements with vendors. Health information should never flow into advertising pixels or analytics tools that are not built for it.

Subscription billing done right. Clear disclosure of recurring charges, affirmative consent, and an easy way to cancel. Federal and state automatic-renewal rules apply to telehealth subscriptions just as they do to any other recurring service.

Telehealth-underwritten merchant processing in your company's name, plus the legal pages every telehealth website needs: terms, privacy policy, telehealth consent, and refund policy.

Do not build a one-ingredient business

A brand that needs one contested ingredient to survive is a bet, not a business. Anchor the catalog on established categories, such as hormone therapy, TRT, weight management, ED, hair and skin, and at-home labs, and let peptides, where lawfully available, extend it. When an FDA determination changes what pharmacies can compound, a diversified brand adjusts a product page. A peptide-only brand starts over.

This also helps acquisition. Symptom-first creative (energy, recovery, sleep, how someone feels at 45 versus 35) brings in patients who may be a fit for several lines of care, and the provider decides which, if any, are appropriate.

The infrastructure list

Here is everything that has to exist before your first legitimate peptide order: a brand and a compliant website, a telehealth platform configured for your intake and provider workflows, CRM and A2P-registered SMS, merchant processing in your name, LegitScript certification, an activated provider network, licensed 503A or 503B pharmacy partners, at-home labs and wearables integration where your protocols use them, end-to-end test orders, a QA pass, and post-launch support. Miss one and the whole system stalls.

If you are evaluating a launch partner, ask direct questions. Whose name is the LegitScript certification issued to? Whose name is the merchant account in? Who decides what goes in the peptide catalog, and how is that list re-checked when the FDA acts? Do they take a share of your revenue or equity? The answers tell you whether you are building an asset or renting one.

How GrowPro builds it with you

GrowPro is a done-for-you telehealth brand launch. One team builds the whole system WITH you: brand, compliant website, WellieMD platform configuration, CRM and SMS, merchant processing in your name, LegitScript filed through our Enterprise account and issued to your company, provider and pharmacy network activation, labs and wearables, test orders, QA, launch, and 30 days of post-launch support. A standard build runs 8 to 12 weeks, and we have launched 80+ brands.

Every vertical is in the base build, and peptides are included where licensed pharmacies can lawfully compound them at the time. We take 0% revenue share and 0% equity, and our founder runs her own telehealth brands on the same infrastructure we build for you.

Once the brand is live, our sister agency Kickstart Social handles compliant, education-first peptide marketing for telehealth brands, from creative to paid campaigns.